Carlos Concha Bascunan

Title: Innovations in Vaccine Development by Carlos Concha Bascunan

Introduction

Carlos Concha Bascunan is an accomplished inventor based in Santiago, Chile. He has made significant contributions to the field of vaccine development, particularly through his innovative research and patenting of new vaccine compositions.

Latest Patents

Carlos Concha Bascunan holds a patent for a vaccine composition that comprises a fibronectin binding protein or a fibronectin binding peptide. This invention relates to a composition that includes at least one fibronectin binding protein, a truncated fibronectin binding protein, and/or a fibronectin binding peptide, all containing at least one fibronectin binding domain. Additionally, the composition includes an iscom matrix complex, liposome, or lipid, along with saponin, which may be in complex, solution, or suspension form. The patent also describes the use of this composition for preparing a vaccine against microorganisms that contain at least one fibronectin binding domain. Furthermore, it includes a kit with compartments for the fibronectin binding components and instructions for use, as well as a method for vaccinating individuals.

Career Highlights

Carlos Concha Bascunan is associated with Isconova AB, a company known for its advancements in vaccine technology. His work has led to the development of innovative solutions that enhance vaccine efficacy and safety.

Collaborations

Throughout his career, Carlos has collaborated with notable colleagues, including Bror Morein and Karin Lövgren Bengtsson. These partnerships have contributed to the advancement of research in the field of immunology and vaccine development.

Conclusion

Carlos Concha Bascunan's contributions to vaccine innovation highlight the importance of research and collaboration in addressing global health challenges. His patented work continues to pave the way for new vaccine technologies that can improve public health outcomes.